In In Vitro Antimalarial Activity of Ashitaba Stem Ethanolic Extract (Angelica keiskei [Miq.] Koidz)
Abstract
Malaria infection is still become a serious and complex health problem in the world. The diffi culty in treating malaria is caused by the resistance of the malaria parasite to synthetic drugs. One alternative to prevent resistance is to use herbal medicines such as the Ashitaba plant (Angelica keiskei [Miq.] Koidz). This study aims to determine the activity of Ashitaba stem ethanol extract as an antimalarial to the Plasmodium falciparum parasite strain 3D7. Ashitaba stem extract was tested for chemical compound content and antimalarial activity against Plasmodium falciparum strain 3D7 with concentrations of 100, 10, 1, 0.1 and 0.01 μg / ml. The test results for the chemical compounds of Ashitaba stem extract were positive for fl avonoids and chalcone compounds. Ashitaba stem extract with a concentration of 100, 10, 1, 0.1 and 0.01 μg / ml had an average resistance value of 67.75%, 46.61%, 32.56%, 19.60%, and 7.56%. The antimalarial activity test results of Ashitaba stem ethanol extract had an IC50 value of 11.07 μg / ml. The antimalarial activity of Ashitaba stem ethanol extract is included in the category of good antimalarial activity because the IC50 value falls within the range of 10-50 μg / ml.
References
Report. Geneva: WHO Press. [diakses tanggal 2
Maret 2019.
2. Kementerian Kesehatan RI. 2017. Profi l Kesehatan
Nusa Tenggara Barat.
3. Nagata. J.,Morino. K., Saito. M. 2007. Eff ects Of
Dietary Angelika Keiskei On Serum ang Liver Lipid
Profi Les, and Body Fat Accumulations in Rats. Journal
Of Nutrition Scientifi c Vitaminology National Institute
Of Health and Nutrition. Tokyo.
4. Okuyama. T., Takata. M., Takayasa. J., Hasegawa.
T., Tokuda. H., Nishino. A., Nishini. H., Iwasima. A.
1991. Antitumor Promotion by Principles Obtained
from Angelica Keiskei. ChemPhram Bull (Tokyo):
39(6) 1604-5.
5. Baba.K., Taniguchi. M., Shibono. M., Minami. H.
2009. The Components and Line Breeding Of Angelica
Keiskei Koidzuma. Bunseki Kagaku, Vol.58 No 12.
6. Guzy. J., Vaskova-Kubalkova, Rozmer. Z., Fodor. K.,
Marekova. M., Poskobrova,. M., and Perjes., P. 2010.
Activation of oxidative stress response by hydroxyl
substituted chalcones and cyclic chalcone analogues
in mitochondria. FEBS Lett. 584: 567 – 570.
7. Aliefman Hakim, Eka Junaidi, Baiq Fara Dwi Rani
Sofia, Yunita Arian, S. A. (2010). Antimalarial
Activity and Phytochemical Screening of Secondary
Metabolites from Heartwood and Root Bark of
Artocarpus Carmmsi Blanco (Moraceae) Jurnal
Farmasi dan Ilmu Kefarmasian Indonesia Vol. 3 No.
1 Juli 2016 32. 8(2), 131–135.
8. Sofi Fajriah & Megawati. 2015. Penapisan Fitokimia
dan Uji Toksisitas dari Daun Myristica Fatua Houtt.
Depok: Departemen Kimia. FMIPA. UI
9. Hafi d, A. F., Puliansari, N., Lestari, N. S., Tumewu,
L., Rahman, A., & Widyawaruyanti, A. (2017).
Skrining Aktivitas Antimalaria Beberapa Tanaman
Indonesia Hasil Eksplorasi Dari Hutan Raya Cangar,
Batu-Malang, Jawa Timur. Jurnal Farmasi Dan
Ilmu Kefarmasian Indonesia, 3(1), 7. https://doi.
org/10.20473/jfi ki.v3i1201.7-11
10. Ilhami. F. Y., Fatma S. W., Elidahanum. H. 2013.
Uji Efek Sitotoksik Hasil Fraksinasi Ekstrak Etanol
Akar Asam Kandis (Garcinia Cowa Roxb) Terhadap
Sel Kanker Payudara T47D Dengan Metode MTT.
Laporan Penelitian. Fakultas Farmasi Universitas
Andalas Padang.
11. Gassler. M.C., Nkunya. M.H.N., Mwasumbi. L.B.,
Heinrich. M., dan Toner. M. 1994. Screening Tanzanian
Medical Plants For Antialarial Activity. Journal Of
Ethnopharmacology, 48(1): 131-144.
12. Sherman. I.W. 1998. Malaria, Parasite Biology,
Pathogenesis, and Protection, Washington. D.C: ASM
Press.
13. Biagini. G.A., Oneill. P.M., Nzila. A., Ward. S.A., and
Bray. A.W. 2003. Antimalarial chemotherapy. Young
gun or back to the future, tren in Parasitilogy 19 (11):
479-487.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Tools
